Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: randomised placebo-controlled double-blind cross-over study

Gilchrist, N.L.; Richards, A.M.; March, R.; Nicholls, M.G.

Journal of Human Hypertension 3(6): 451-455

1989


ISSN/ISBN: 0950-9240
PMID: 2691690
Document Number: 332781
The effect of sulindac on ACE inhibitor-induced cough was studied in eight hypertensive subjects in a randomised placebo-controlled double blind cross-over trial. There was no significant improvement in cough or sense of well-being. Blood pressure, renal function, plasma renin and ACE activity were unchanged. Sulindac however, appears to be effective in some individuals in reducing ACE inhibitor-induced cough with acceptable tolerance and few side effects. Further work is needed to elucidate the mechanism of sulindac's interaction with ACE inhibitors.

Document emailed within 1 workday
Secure & encrypted payments